Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 444-452 , April 2010

Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review

  • Panagiotis Peitsidis

      Affiliations

    • The Royal Free and University College Medical School, University College London, Gower Street, London, UK
    • Both authors contributed equally to this review.
    • ,
  • Rina Agrawal

      Affiliations

    • University College London, Gower Street, London, UK
    • Corresponding Author InformationCorresponding author.
    • Both authors contributed equally to this review.

Received 23 June 2009 ,Revised 11 August 2009 ,Accepted 3 December 2009.

References 

  1. Abd El Aal DE, Mohamed SA, Amine AF, et al. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005;1:219–224
  2. Aboulghar MA, Mansour RT, Serour GI, et al. Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. J. Assist. Reprod. Genet. 1992;9:238–243
  3. Abramov Y, Barak V, Nisman B, Schenker JG. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril. 1997;67:261–265
  4. Agrawal R, Conway G, Sladkevicius P, et al. Serum vascular endothelial growth factor and Doppler blood flow velocities in in-vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil. Steril. 1998;70:651–658
  5. Agrawal R, Jacobs H, Payne N, Conway G. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil. Steril. 2002;78:1164–1169
  6. Agrawal R, Sladkevicius P, Engmann L, et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum. Reprod. 1998;13:651–655
  7. Aleem FA, Predanic M. Transvaginal colour Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil. Steril. 1996;65:510–516
  8. Amin AF, Abd el-Aal DE, Darwish AM, Meki AR. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome. Fertil. Steril. 2003;79:938–941
  9. Artini PG, Fasciani A, Monti M, et al. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation in women enrolled in an in-vitro fertilization program. Fertil. Steril. 1998;70:560–564
  10. Artini PG, Monti M, Matteucci C, et al. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol. Endocrinol. 2006;22:465–470
  11. Artini PG, Ruggiero M, Parisen Toldin MR, et al. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum. Fertil. (Camb.). 2009;12:40–44
  12. Artini PG, Ruggiero M, Parisen Toldin MR, Monteleone P, Monti M, Cela V, et al. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum. Fertil. (Camb.). 2009;12(1):40–44
  13. Babayof R, Margalioth EJ, Huleihel M, et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum. Reprod. 2006;21:1260–1265
  14. Balen, A., 2005. Ovarian hyperstimulation syndrome – a short report for the HFEA.
  15. Battaglia C, Artini PG, D’Ambrogio G, et al. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am. J. Obstet. Gynecol. 1995;172:108–113
  16. Bider D, Menashe Y, Oelsner G, et al. Ovarian hyperstimulation due to exogenous gonadotrophin administration. Acta Obstet. Gynecol. Scand. 1989;69:511–514
  17. Bokal EV, Virant Klun I, Verdenik I. Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. Reprod. Biomed. Online. 2009;18(1):21–28
  18. Bokal EV, Vrtovec HM, Virant Klun I, Verdenik I. Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome. Hum. Reprod. 2005;20:1562–1568
  19. Charbonnel B, Krempf M, Blanchard P, et al. Induction of ovulation in polycystic ovary syndrome with a combination of luteinizing hormone releasing hormone analogue and exogenous gonadotropins. Fertil. Steril. 1987;47:920–924
  20. Delvigne A, Demoulin A, Smitz J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicenter study. I. Clinical and biological features. Hum. Reprod. 1993;8:1353–1360
  21. Delvigne A, Dubois M, Battheu B, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicenter study. II. Multiple discriminant analysis for risk prediction. Hum. Reprod. 1993;8:1361–1366
  22. Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS. 2005;(94):209–231
  23. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997;18:4–25
  24. Ferrara N, Frantz G, LeCouter J, et al. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am. J. Pathol. 2003;162(6):1881–1893
  25. Friedman CI, Seifer DB, Kennard EA, et al. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil. Steril. 1998;70:836–839
  26. García-Velasco JA, Pellicer A. New concepts in the understanding of the ovarian hyperstimulation syndrome. Curr. Opin. Obstet. Gynecol. 2003;15:251–256
  27. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil. Steril. 2002;74:429–438
  28. Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005;6(2):209
  29. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 1995;146(1):157–165
  30. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo KT. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril. 1996;65:552–555
  31. Lee EJ, Oh B, Lee JY, et al. Association study between single nucleotide polymorphisms in the VEGF gene and polycystic ovary syndrome. Fertil. Steril. 2008;89:1751–1759
  32. Levin ER, Rosen GF, Cassidenti DL, et al. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J. Clin. Invest. 1998;102(11):1978–1985
  33. MacDougall MJ, Tan SL, Jacobs HS. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod. 1992;7(5):597–600
  34. MacDougall JM, Tan SL, Balen AH, et al. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod. 1993;8:233–237
  35. Malamitsi-Puchner A, Sarandakou A, Baka SG, et al. Concentrations of angiogenic factors in follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: association with oocyte maturity and fertilization. Fertil. Steril. 2001;76(1):98–101
  36. McClure N, Healy DL, Rogers PA, et al. Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet. 1994;344:235–2243
  37. Meldrum DR. Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome. Fertil. Steril. 2002;78:1170–1171
  38. Neulen J, Raczek S, Pogorzelski M, et al. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol. Hum. Reprod. 1998;4:203–206
  39. Ng EH, Chan CC, Yeung WS, Ho PC. Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome. Hum. Reprod. 2005;7:1881–1886
  40. Rizk B, Aboulghar M. Modern management of ovarian hyperstimulation syndrome. Hum. Reprod. 1991;6(8):1082–1087
  41. Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril. 1978;30:255–268
  42. Smitz J, Camus M, Devroey P, et al. Incidence of severe ovarian hyperstimulation syndrome after GnRH-agonist/HMG superovulation for in-vitro fertilization. Hum. Reprod. 1990;5:933–937
  43. Stanek MB, Borman SM, Molskness TA, et al. Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women. J. Clin. Endocrinol. Metab. 2007;92:2726–2733
  44. Tamanini C, De Ambrogi M. Angiogenesis in developing follicle and corpus luteum. Reprod. Domest. Anim. 2004;39:206–216
  45. Tulandi T, Saleh A, Morris D, et al. Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome. Fertil. Steril. 2000;74:585–588
  46. Van Blerkom J, Antczak M, Schrander R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum. Reprod. 1997;12:1047–1055
  47. Zaidi J, Campbell S, Pitroff R, et al. Ovarian stromal blood flow in women with polycystic ovaries a possible new marker for diagnosis?. Hum. Reprod. 1995;10:1992–1996

 Panagiotis Peitsidis MD, PhD completed his training in Obstetrics and Gynaecology in Athens, Greece. Since 2008, he has been working as a Clinical Research Fellow in the department of Obstetrics and Gynaecology at The Royal Free Hospital in London, UK. His research interests include fetal medicine, ultrasound, colposcopy, and gynecological oncology. He is a referee for several medical journals and has published extensively. He recently received his PhD from the University of Athens on prognostic factors in patients with Fallopian tube cancer.

PII: S1472-6483(10)00009-X

doi: 10.1016/j.rbmo.2010.01.007

Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 444-452 , April 2010

Article Tools

* Image Usage & Resolution